MedTrace Logo

Pre-op Rectal ChemoRad +/- Cetuximab

NCT00527111 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 139

Last updated 2016-11-03

Study results available
· View outcomes & findings →

Summary

The purpose of this research study is to find out what effects (good and bad) cetuximab has on rectal cancer.

Conditions

Interventions

DRUG

Cetuximab

DRUG

5-fluorouracil

RADIATION

Pelvic irradiation

Sponsors & Collaborators

Principal Investigators

  • Andrew D McCollum, MD · US Oncology Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00527111 on ClinicalTrials.gov